SA author Charles Moscoe, who states he's a "consultant for a major player in the electronic cigarette space," believes mCig (MCIG -11.4%) "has no proprietary technology," and that similar Chinese OEM products can be easily procured.
Moscoe also: 1) Notes mCig had Q3 revenue of just $85,109. 2) Argues mCig's VitaCig unit (set to be spun off) "competes in [a] highly fragmented electronic cigarette market" dominated by Lorillard and Altria. 3) Notes the company's recently acquired glass vaporizer product has only seen sales of $2M over the last 13 years.
Updated March 25, 7:26 p.m.: After talking with mCig CEO Paul Rosenberg, Moscoe substitutes an author update for his original piece. Moscoe says he's now "able to see the differences between the mCig 2.0 and the devices I had originally compared it with," and says the fact mCig's primary product (mCig 2.0) only launched 60 days ago suggests the company's story is "still in its infancy." But he maintains it's "extraordinarily overvalued." MCIG +2% today.